Annual CAPEX
N/A
December 31, 2023
Summary
- MRKR annual capital expenditures is not available.
Performance
MRKR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- MRKR quarterly capital expenditures is not available.
Performance
MRKR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- MRKR TTM capital expenditures is not available.
Performance
MRKR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MRKR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MRKR CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Marker Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | - | $4.10 M(+234.9%) | $9.25 M(+79.1%) |
| Sep 2020 | - | $1.22 M(-68.0%) | $5.17 M(+29.2%) |
| Jun 2020 | - | $3.83 M(+3736.2%) | $4.00 M(+1488.4%) |
| Mar 2020 | - | $99.80 K(+673.6%) | $251.70 K(-32.9%) |
| Dec 2019 | $375.00 K(+153.9%) | $12.90 K(-77.2%) | $375.00 K(+3.6%) |
| Sep 2019 | - | $56.70 K(-31.1%) | $362.10 K(+18.6%) |
| Jun 2019 | - | $82.30 K(-63.1%) | $305.40 K(+36.9%) |
| Mar 2019 | - | $223.10 K(>+9900.0%) | $223.10 K(+896.0%) |
| Dec 2018 | $147.70 K(+559.4%) | - | - |
| Dec 2007 | $22.40 K(+1020.0%) | $0.00(-100.0%) | $22.40 K(0.0%) |
| Sep 2007 | - | $1300.00(+8.3%) | $22.40 K(+6.2%) |
| Jun 2007 | - | $1200.00(-94.0%) | $21.10 K(+6.0%) |
| Mar 2007 | - | $19.90 K(>+9900.0%) | $19.90 K(+895.0%) |
| Dec 2005 | $2000.00 | $0.00(0.0%) | $2000.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2005 | - | $0.00(0.0%) | $2000.00(0.0%) |
| Jun 2005 | - | $0.00(-100.0%) | $2000.00(0.0%) |
| Mar 2005 | - | $2000.00(>+9900.0%) | $2000.00(-9.1%) |
| Dec 2003 | $2300.00(-60.3%) | $0.00(-100.0%) | $2200.00(0.0%) |
| Sep 2003 | - | $1400.00(+366.7%) | $2200.00(+175.0%) |
| Jun 2003 | - | $300.00(-40.0%) | $800.00(+60.0%) |
| Mar 2003 | - | $500.00(-100.7%) | $500.00(>+9900.0%) |
| Dec 2002 | $5800.00(+100.0%) | - | - |
| Dec 2001 | - | -$68.70 K(-200.0%) | $0.00(-100.0%) |
| Sep 2001 | - | $68.70 K(<-9900.0%) | $68.40 K(+2258.6%) |
| Dec 2000 | $2900.00(-94.6%) | -$300.00(<-9900.0%) | $2900.00(-9.4%) |
| Sep 2000 | - | $0.00(-100.0%) | $3200.00(0.0%) |
| Jun 2000 | - | $1300.00(-31.6%) | $3200.00(+68.4%) |
| Mar 2000 | - | $1900.00 | $1900.00 |
| Dec 1999 | $54.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Marker Therapeutics?
- What is the all time high quarterly CAPEX for Marker Therapeutics?
- What is the all time high TTM CAPEX for Marker Therapeutics?
What is the all time high annual CAPEX for Marker Therapeutics?
Marker Therapeutics all-time high annual capital expenditures is $375.00 K
What is the all time high quarterly CAPEX for Marker Therapeutics?
Marker Therapeutics all-time high quarterly capital expenditures is $4.10 M
What is the all time high TTM CAPEX for Marker Therapeutics?
Marker Therapeutics all-time high TTM capital expenditures is $9.25 M